Velsipity 2 MG Oral Tablet
- RxCUI
- 2668057
- RxNorm name
- Velsipity 2 MG Oral Tablet
- Display name
- Velsipity 2 MG Oral Tablet
- Full name
- Velsipity 2 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Velsipity | ETRASIMOD | Pfizer Laboratories Div Pfizer Inc | 65171e4a-d136-4abc-b08c-c40c1b486ff6 | 2025-08-18 | Warnings, Adverse reactions | 2668057 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 65171e4a-d136-4abc-b08c-c40c1b486ff6 | Velsipity 2 MG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use VELSIPITY safely and effectively. See full prescribing information for VELSIPITY. VELSIPITY™ (etrasimod) tablets, for oral use Initial U.S. Approval: 2023 | 20250818 |
| 65171e4a-d136-4abc-b08c-c40c1b486ff6 | Velsipity 2 MG Oral Tablet | SY | 4 | These highlights do not include all the information needed to use VELSIPITY safely and effectively. See full prescribing information for VELSIPITY. VELSIPITY™ (etrasimod) tablets, for oral use Initial U.S. Approval: 2023 | 20250818 |
| 65171e4a-d136-4abc-b08c-c40c1b486ff6 | etrasimod 2 MG Oral Tablet [Velsipity] | SBD | 4 | These highlights do not include all the information needed to use VELSIPITY safely and effectively. See full prescribing information for VELSIPITY. VELSIPITY™ (etrasimod) tablets, for oral use Initial U.S. Approval: 2023 | 20250818 |